HONSUN (NANTONG) Co., Ltd.
⚠️ High Risk
FEI: 3007740533 • Nantong City, Jiangsu • CHINA
FEI Number
3007740533
Location
Nantong City, Jiangsu
Country
CHINAAddress
Economic & Technical, NO. 8 Tongxing Road; Development Area, Nantong City, Jiangsu, China
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
DV QUALITY
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be adulterated since its strength differs from, or its purity or quality falls below, that which it purports or is represented to possess.
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
FAILS STD
The article appears to be a device which is subject to a performance standard established under Section 514 and does not appear to be in all respects in conformity with such standard.
NO 510(K)
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it is a post 1976 device for which a Section 510(k)application does not appear to have been determined substantially equivalent or otherwise filed.
LACKS FIRM
The article is in package form and appears to not bear a label containing the name and place of business of the manufacturer, packer, or distributor.
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
INCONSPICU
Information required by the Act to be on the label or labeling does not appear to be conspicuous enough as to render it likely to be read and understood by the ordinary individual under customary conditions of purchase and use.
REGISTERED
It appears the device is subject to listing under 510(j) and the initial distributor has not registered as required by 21 CFR 807.20 (a)(5).
3904
3905
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 6/25/2025 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 6/25/2025 | 75NBWSYSTEM, TEST, BLOOD GLUCOSE, OVER THE COUNTER | 118NOT LISTED | Division of West Coast Imports (DWCI) |
| 6/25/2025 | 75NBWSYSTEM, TEST, BLOOD GLUCOSE, OVER THE COUNTER | 118NOT LISTED | Division of West Coast Imports (DWCI) |
| 6/25/2025 | 75NBWSYSTEM, TEST, BLOOD GLUCOSE, OVER THE COUNTER | 118NOT LISTED | Division of West Coast Imports (DWCI) |
| 2/20/2025 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Southeast Imports (DSEI) |
| 1/13/2025 | 74DXQCUFF, BLOOD-PRESSURE | Division of West Coast Imports (DWCI) | |
| 1/13/2025 | 74DXNSYSTEM, MEASUREMENT, BLOOD-PRESSURE, NON-INVASIVE | Division of West Coast Imports (DWCI) | |
| 12/10/2024 | 73CAFNEBULIZER (DIRECT PATIENT INTERFACE) | 508NO 510(K) | Division of Southeast Imports (DSEI) |
| 12/6/2024 | 74DXQCUFF, BLOOD-PRESSURE | Division of Southeast Imports (DSEI) | |
| 12/6/2024 | 74LDESTETHOSCOPE, MANUAL | Division of Southeast Imports (DSEI) | |
| 11/18/2024 | 74OEDANTIMICROBIAL BLOOD PRESSURE CUFF | 479DV QUALITY | Division of Northern Border Imports (DNBI) |
| 2/14/2024 | 74DXQCUFF, BLOOD-PRESSURE | Division of West Coast Imports (DWCI) | |
| 9/13/2023 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Northern Border Imports (DNBI) |
| 1/17/2023 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Northern Border Imports (DNBI) |
| 1/3/2022 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 12/29/2021 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Northern Border Imports (DNBI) |
| 12/27/2021 | 74DXQCUFF, BLOOD-PRESSURE | Division of Southeast Imports (DSEI) | |
| 12/15/2021 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Northeast Imports (DNEI) |
| 11/23/2021 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Northern Border Imports (DNBI) |
| 11/3/2021 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Northeast Imports (DNEI) |
| 11/3/2021 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Southwest Imports (DSWI) |
| 11/2/2021 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Southeast Imports (DSEI) |
| 12/8/2020 | 73CAFNEBULIZER (DIRECT PATIENT INTERFACE) | Division of West Coast Imports (DWCI) | |
| 7/27/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Southwest Imports (DSWI) |
| 6/3/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Southeast Imports (DSEI) |
| 6/3/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Southeast Imports (DSEI) |
| 3/17/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 3/17/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 3/17/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 3/17/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 3/17/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 3/17/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 3/17/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 3/17/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 3/17/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 3/17/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 3/17/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 1/17/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Southeast Imports (DSEI) |
| 1/17/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Southeast Imports (DSEI) |
| 1/17/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Southeast Imports (DSEI) |
| 1/17/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Southeast Imports (DSEI) |
| 1/17/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Southeast Imports (DSEI) |
| 1/17/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Southeast Imports (DSEI) |
| 1/13/2020 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 1/2/2020 | 74DXQCUFF, BLOOD-PRESSURE | 126FAILS STD | Division of Northeast Imports (DNEI) |
| 1/2/2020 | 74DXQCUFF, BLOOD-PRESSURE | 126FAILS STD | Division of Northeast Imports (DNEI) |
| 1/2/2020 | 74DXQCUFF, BLOOD-PRESSURE | 126FAILS STD | Division of Northeast Imports (DNEI) |
| 1/2/2020 | 74DXQCUFF, BLOOD-PRESSURE | 126FAILS STD | Division of Northeast Imports (DNEI) |
| 1/2/2020 | 74DXQCUFF, BLOOD-PRESSURE | 126FAILS STD | Division of Northeast Imports (DNEI) |
| 1/2/2020 | 74DXQCUFF, BLOOD-PRESSURE | 126FAILS STD | Division of Northeast Imports (DNEI) |
| 12/16/2019 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 12/11/2019 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Southeast Imports (DSEI) |
| 12/10/2019 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Northeast Imports (DNEI) |
| 12/10/2019 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Northeast Imports (DNEI) |
| 11/27/2019 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 11/1/2019 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Northern Border Imports (DNBI) |
| 11/1/2019 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Northern Border Imports (DNBI) |
| 10/30/2019 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Southwest Imports (DSWI) |
| 10/7/2019 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 8/20/2019 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 2/6/2019 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 2/6/2019 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of West Coast Imports (DWCI) |
| 9/14/2018 | 74DXQCUFF, BLOOD-PRESSURE | 479DV QUALITY | Division of Southeast Imports (DSEI) |
| 7/17/2015 | 74DXQCUFF, BLOOD-PRESSURE | 333LACKS FIRM | Cincinnati District Office (CIN-DO) |
Frequently Asked Questions
What is HONSUN (NANTONG) Co., Ltd.'s FDA import refusal history?
HONSUN (NANTONG) Co., Ltd. (FEI: 3007740533) has 64 FDA import refusal record(s) in our database, spanning from 7/17/2015 to 6/25/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. HONSUN (NANTONG) Co., Ltd.'s FEI number is 3007740533.
What types of violations has HONSUN (NANTONG) Co., Ltd. received?
HONSUN (NANTONG) Co., Ltd. has been cited for 10 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about HONSUN (NANTONG) Co., Ltd. come from?
All FDA import refusal data for HONSUN (NANTONG) Co., Ltd. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.